Ride Therapeutics Limited

Ride Therapeutics is a recently formed transatlantic biotechnology company with the mission of unlocking the full potential of mRNA & gene editing therapeutics through targeted & tunable delivery of these modalities. Founded by world-leading scientists from Harvard University & the University of Cambridge, Ride’s unique technology platform provides an entirely new approach to solving the delivery challenge at the molecular level. Powered by micro- and nano-engineering coupled to advanced data science, Ride is building the capability to deliver any molecular cargo, to any cell type, with a tunable release profile.